Kenneth Gao, MBA
Kenneth Gao serves as VP of Alliance Management and Corporate Development at Overland Pharmaceuticals.
Prior to Overland, Kenneth most recently served as Senior Director of Corporate Development and Strategy as well as Head of China Operations at Assembly Biosciences. At Assembly Kenneth spearheaded establishment of Assembly China, led teams to execute strategic partnerships for assets in all development stages across the globe, and co-led multiple rounds of follow-on capital raising on Nasdaq. Before Assembly, he held various managerial positions in management consulting, transactions, and business operations at IMS Health, Eli Lilly, and Becton Dickinson. Kenneth also worked at Ennovance Capital, focused on mid-market private equity investments in the specialty chemical and pharmaceutical sectors.
Kenneth received an MBA in Health Sector Management from Duke University and a BS in Business Administration from State University of New York at Buffalo, NY.